Klotho Neurosciences Faces Nasdaq Delisting Warning
Ticker: GRMLW · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1907223
Sentiment: bearish
Topics: delisting-warning, compliance, nasdaq
Related Tickers: KLTO
TL;DR
KLTO got a Nasdaq delisting warning, needs to hit $1 bid price by Oct 13 to stay listed.
AI Summary
Klotho Neurosciences, Inc. has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requirement for continued listing. The company has until October 13, 2025, to regain compliance by achieving a closing bid price of $1.00 or more for a minimum of 10 consecutive business days.
Why It Matters
Failure to meet the minimum bid price could lead to delisting from the Nasdaq, potentially impacting the stock's liquidity and investor confidence.
Risk Assessment
Risk Level: high — The company is at high risk of delisting from the Nasdaq if it cannot meet the minimum bid price requirement.
Key Numbers
- $1.00 — Minimum Bid Price (Requirement for continued Nasdaq listing)
- October 13, 2025 — Compliance Deadline (Date by which bid price must be met)
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- Nasdaq Stock Market (company) — Listing Exchange
- $1.00 (dollar_amount) — Minimum bid price requirement
- October 13, 2025 (date) — Compliance deadline
FAQ
What is the specific reason Klotho Neurosciences received a delisting warning?
Klotho Neurosciences received the warning because its stock has not maintained a minimum closing bid price of $1.00 per share.
What is the deadline for Klotho Neurosciences to regain compliance with Nasdaq's listing rules?
The company has until October 13, 2025, to regain compliance.
What action must Klotho Neurosciences take to avoid delisting?
Klotho Neurosciences must achieve a closing bid price of $1.00 or more for a minimum of 10 consecutive business days.
What is the ticker symbol for Klotho Neurosciences?
The ticker symbol for Klotho Neurosciences is KLTO.
What is the company's primary business focus?
Klotho Neurosciences, Inc. is focused on biological products, specifically in the area of neurosciences.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).